British Patient Diagnosed with Cancer During Health Screening in ChinaPrecision Treatment in Shanghai Achieves Complete Remission Spleen-Preserving Surgery

While visiting Shanghai in 2024, the patient underwent a comprehensive health screening at a friend’s recommendation despite having no noticeable symptoms. An elevated CEA level was unexpectedly detected, and subsequent endoscopic and pathological examinations confirmed gastroesophageal junction adenocarcinoma with poor differentiation. Due to the absence of symptoms and the early-stage discovery, a critical window for curative treatment was successfully secured.

 

Following recommendations from his UK family doctor, the patient chose to remain in China for treatment, citing excessive waiting times within the UK

healthcare system.

 

A multidisciplinary team (MDT) at xx Hospital developed a personalized treatment strategy combining neoadjuvant chemotherapy, PD-1 immunotherapy, and surgery. Post-operative pathology demonstrated pathological complete response (pCR), with complete disappearance of tumor cells, achieving the clinical standard for complete remission.

 

After reviewing the treatment plan, the family doctor in the UK commented,  “The treatment you received in China surpasses what you would typically receive in the West.” The patient later described the routine health screening as “that was the best decision I ever made..”